MPP+Produces Progressive Neuronal Degeneration Which Is Mediated by Oxidative Stress
- 31 March 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 144 (1), 193-198
- https://doi.org/10.1006/exnr.1997.6416
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonateAnnals of Neurology, 1994
- Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.Proceedings of the National Academy of Sciences, 1994
- Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3-6-tetrahydropyridine (MPTP)-treated ratNeuroscience Letters, 1993
- MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymesFree Radical Biology & Medicine, 1993
- Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboonsNeuroscience, 1993
- Alternative excitotoxic hypothesesNeurology, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992
- Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse BrainJournal of Neurochemistry, 1991
- The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseJournal of the Neurological Sciences, 1990